| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8aebc762914a0aac859dd4bc8b558617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d4424bcc6bce434e2eef0f50134c45a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d04c7142d85d086f9b461175b2e7962
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_daaacf2faeca68f22e7ca2d8167e1d9a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 |
| filingDate |
2008-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50e91e0473a830a187b92d9db06d048e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb5796589437bdb589adc751797eb913
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41c6c719ce9c727341dcefcb44b7875b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62262f8cfa1fd8cdf970f46695d1c502 |
| publicationDate |
2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008187589-A1 |
| titleOfInvention |
Multi-modal delivery via transmucosal and gastro-intestinal absorption of antihistamines and symptom relief |
| abstract |
A multi-modal absorption, medicine-delivery lozenge is provided. The lozenge includes a lozenge base for oral administration into a user's mouth, a medicinal active ingredient including an antihistamine convertible between ionized and non-ionized states, and a buffer present in an effective amount for establishing a pH in the individual's mouth which is characterized by a simultaneous presence of a first pharmacologically effective dose of the non-ionized form of the medicinal active ingredient for transmucosal absorption, and a second pharmacologically effective dose of the ionized form of the medicinal active ingredient for gastro-intestinal absorption. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11241397-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010044736-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010124560-A1 |
| priorityDate |
2007-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |